Skip to main content
Premium Trial:

Request an Annual Quote

NIAID s Bioinformatics Spending Spree: Agency Commits $79M to Network of Biodefense BRCs

Premium

Last week, the National Institute of Allergy and Infectious Diseases awarded around $79 million in five-year contracts to establish six national Bioinformatics Research Centers that will support research in biodefense and infectious disease (see table, below, for details of awards).

The BRCs will coordinate genomics, proteomics, biochemical, and microbiological information related to multiple organisms that NIAID has identified as Category A, B, or C pathogens. The centers will be responsible for developing and maintaining relational databases to collect a variety of data types, such as genome sequence, comparative genomics data, genome polymorphisms, gene expression data, proteomics, host/pathogen interactions, and pathways. The BRCs will also provide data analysis tools, as well as training for the general scientific community on how to use and interpret data contained in the database.

The bioinformatics funding follows a parallel effort that NIAID has underway in proteomics. BioInform’s sister publication ProteoMonitor reported last week that the agency has awarded more than $54 million so far for five biodefense-related proteomics contracts, and plans to award two more contracts under the same program.

Valentina Di Francesco, bioinformatics program director in NIAID’s Division of Microbiology and Infectious Diseases, said that the agency may award several more BRC contracts in the next few months, but declined to provide further details.

Di Francesco said that the goal of the BRCs is to “collect, consolidate, and integrate” publicly available information on microbial pathogens that is currently dispersed throughout the research community. NIAID made sure that each of the pathgens it had identified would be covered by at least one center, she said, with “as little redundancy as possible.” In addition, she said, “We hope to have the centers coordinate with each other and collaborate with each other” in areas such as the development of standards for data exchange

—BT

File Attachments

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.